THE BIOLOGICAL SPECIATION AND TOXICOKINETICS OF ALUMINUM

被引:81
作者
DEVOTO, E
YOKEL, RA
机构
[1] UNIV N CAROLINA, SCH PUBL HLTH, DEPT ENVIRONM SCI & ENGN, CHAPEL HILL, NC 27599 USA
[2] UNIV KENTUCKY, COLL PHARM, DIV PHARMACOL & EXPTL THERAPEUT, LEXINGTON, KY 40536 USA
[3] UNIV KENTUCKY, GRAD CTR TOXICOL, LEXINGTON, KY 40536 USA
关键词
ABSORPTION; ALUMINUM; CITRATE; EQUILIBRIUM MODELING; NMR; PHARMACOKINETICS; PLASMA; SPECIATION; TRANSFERRIN; UREMIA;
D O I
10.2307/3431916
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This review discusses recent literature on the chemical and physiological factors that influence the absorption, distribution, and excretion of aluminum in mammals, with particular regard to gastrointestinal absorption and speciation in plasma. Humans encounter aluminum, a ubiquitous yet highly insoluble element in most forms, in foods, drinking water, and pharmaceuticals. Exposure also occurs by inhalation of dust and aerosols, particularly in occupational settings. Absorption from the gut depends largely on pH and the presence of complexing ligands, particularly carboxylic acids, with which the metal can form absorbable neutral aluminum species. Uremic animals and humans experience higher than normal body burdens of aluminum despite increased urinary clearance of the metal. In plasma, 80-90% of aluminum binds to transferrin, an iron-transport protein for which receptors exist in many tissues. The remaining fraction of plasma aluminum takes the form of small-molecule hydroxy species and small complexes with carboxylic acids, phosphate, and, to a much lesser degree, amino acids. Most of these species have not been observed in vivo but are predicted from equilibrium models derived from potentiometric methods and NMR investigations. These models predict that the major small-molecule aluminum species under plasma conditions are charged and hence unavailable for uptake into tissues.
引用
收藏
页码:940 / 951
页数:12
相关论文
共 110 条
[1]   IRON TRANSPORT AND STORAGE PROTEINS [J].
AISEN, P ;
LISTOWSKY, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1980, 49 :357-393
[2]  
AKIRT JW, 1989, PROG NMR SPECTROM, V21, P1
[3]   METABOLISM AND TOXICITY OF ALUMINUM IN RENAL-FAILURE [J].
ALFREY, AC ;
HEGG, A ;
CRASWELL, P .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1980, 33 (07) :1509-1516
[4]   DISSIMILAR ALUMINUM AND GALLIUM PERMEATION OF THE BLOOD-BRAIN-BARRIER DEMONSTRATED BY INVIVO MICRODIALYSIS [J].
ALLEN, DD ;
YOKEL, RA .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (03) :903-908
[5]  
ANDERSEN JR, 1987, TRACE ELEM MED, V4, P42
[6]   DEMENTIA, RENAL-FAILURE, AND BRAIN ALUMINUM [J].
ARIEFF, AI ;
COOPER, JD ;
ARMSTRONG, D ;
LAZAROWITZ, VC .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (05) :741-747
[7]  
BERSKETH RO, 1980, CONTROVERSIES NEPHRO, V2, P42
[8]  
BERTHOLF RL, 1984, BIOCHEM BIOPH RES CO, V125, P1020, DOI 10.1016/0006-291X(84)91385-8
[9]  
BERTHOLF RL, 1985, CLIN PHYSIOL BIOCH, V3, P271
[10]  
BERTHON G, 1992, J AM COLL NUTR, V11, P340